Improving risk stratification in acute pulmonary embolism: How do we target our therapies more effectively?

Vasc Med. 2021 Oct;26(5):561-562. doi: 10.1177/1358863X211021917. Epub 2021 Jun 23.

Authors

Robert S Zilinyi¹, Sanjum S Sethi²

Affiliations

¹ Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
² Department of Medicine, Division of Cardiology, Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, NY, USA.

PMID: 34159862
DOI: 10.1177/1358863X211021917

No abstract available

Keywords: biomarkers; pulmonary embolism (PE); risk stratification.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Humans
Prognosis
Pulmonary Embolism* / diagnosis
Pulmonary Embolism* / therapy
Risk Assessment